First Time Loading...
F

Fresenius SE & Co KGaA
XETRA:FRE

Watchlist Manager
Fresenius SE & Co KGaA
XETRA:FRE
Watchlist
Price: 27.89 EUR 0.07%
Updated: May 7, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Fresenius SE & Co KGaA

Revenue
22.3B EUR
Cost of Revenue
-17.2B EUR
Gross Profit
5.1B EUR
Operating Expenses
-3.9B EUR
Operating Income
1.2B EUR
Other Expenses
-1.8B EUR
Net Income
-594m EUR

Margins Comparison
Fresenius SE & Co KGaA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.6B EUR
23%
5%
-3%
US
Cigna Group
XMUN:CGN
90.8B EUR
12%
5%
2%
US
Cigna Corp
NYSE:CI
97.3B USD
12%
5%
2%
US
CVS Health Corp
NYSE:CVS
70.1B USD
15%
4%
2%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.9B USD
28%
9%
4%
US
Quest Diagnostics Inc
NYSE:DGX
15.1B USD
33%
14%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.9B EUR
25%
7%
3%
DE
Fresenius Medical Care AG
XMUN:FME
11.5B EUR
25%
7%
3%
US
DaVita Inc
NYSE:DVA
12B USD
32%
14%
7%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
4%
-22%
-24%
US
Chemed Corp
NYSE:CHE
8.6B USD
35%
16%
12%
Country DE
Market Cap 15.6B EUR
Gross Margin
23%
Operating Margin
5%
Net Margin
-3%
Country US
Market Cap 90.8B EUR
Gross Margin
12%
Operating Margin
5%
Net Margin
2%
Country US
Market Cap 97.3B USD
Gross Margin
12%
Operating Margin
5%
Net Margin
2%
Country US
Market Cap 70.1B USD
Gross Margin
15%
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 16.9B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
4%
Country US
Market Cap 15.1B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 10.9B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country DE
Market Cap 11.5B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 12B USD
Gross Margin
32%
Operating Margin
14%
Net Margin
7%
Country US
Market Cap 9.5B USD
Gross Margin
4%
Operating Margin
-22%
Net Margin
-24%
Country US
Market Cap 8.6B USD
Gross Margin
35%
Operating Margin
16%
Net Margin
12%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Fresenius SE & Co KGaA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.6B EUR
-3%
-1%
2%
1%
US
Cigna Group
XMUN:CGN
90.8B EUR
8%
2%
9%
7%
US
Cigna Corp
NYSE:CI
97.3B USD
8%
2%
9%
7%
US
CVS Health Corp
NYSE:CVS
70.1B USD
10%
3%
8%
6%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.9B USD
5%
2%
7%
4%
US
Quest Diagnostics Inc
NYSE:DGX
15.1B USD
13%
6%
11%
8%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.9B EUR
4%
1%
4%
3%
DE
Fresenius Medical Care AG
XMUN:FME
11.5B EUR
4%
1%
4%
3%
US
DaVita Inc
NYSE:DVA
12B USD
93%
5%
12%
9%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
464%
-26%
-41%
-35%
US
Chemed Corp
NYSE:CHE
8.6B USD
27%
18%
29%
22%
Country DE
Market Cap 15.6B EUR
ROE
-3%
ROA
-1%
ROCE
2%
ROIC
1%
Country US
Market Cap 90.8B EUR
ROE
8%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 97.3B USD
ROE
8%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 70.1B USD
ROE
10%
ROA
3%
ROCE
8%
ROIC
6%
Country US
Market Cap 16.9B USD
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country US
Market Cap 15.1B USD
ROE
13%
ROA
6%
ROCE
11%
ROIC
8%
Country DE
Market Cap 10.9B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country DE
Market Cap 11.5B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country US
Market Cap 12B USD
ROE
93%
ROA
5%
ROCE
12%
ROIC
9%
Country US
Market Cap 9.5B USD
ROE
464%
ROA
-26%
ROCE
-41%
ROIC
-35%
Country US
Market Cap 8.6B USD
ROE
27%
ROA
18%
ROCE
29%
ROIC
22%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More